Essler M - Search Results

1

Test-retest repeatability of organ uptake on PSMA-targeted ¹⁸ F-DCFPyL PET/CT in patients with prostate cancer.

Werner RA, Lütje S, Habacha B, Bundschuh L, Higuchi T, Buck AK, Kosmala A, Lapa C, Essler M, Lodge MA, Pienta KJ, Eisenberger MA, Markowski MC, Gorin MA, Pomper MG, Rowe SP, Bundschuh RA. Werner RA, et al. Among authors: essler m. Prostate. 2023 Sep;83(12):1186-1192. doi: 10.1002/pros.24577. Epub 2023 May 21. Prostate. 2023. PMID: 37211963

2

Lack of repeatability of radiomic features derived from PET scans: Results from a ¹⁸ F-DCFPyL test-retest cohort.

Werner RA, Habacha B, Lütje S, Bundschuh L, Kosmala A, Essler M, Derlin T, Higuchi T, Lapa C, Buck AK, Pienta KJ, Lodge MA, Eisenberger MA, Markowski MC, Pomper MG, Gorin MA, Frey EC, Rowe SP, Bundschuh RA. Werner RA, et al. Among authors: essler m. Prostate. 2023 May;83(6):547-554. doi: 10.1002/pros.24483. Epub 2023 Jan 11. Prostate. 2023. PMID: 36632656

3

¹⁷⁷Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer and Prior ²²³Ra (RALU Study).

Rahbar K, Essler M, Eiber M, la Fougère C, Prasad V, Fendler WP, Rassek P, Hasa E, Dittmann H, Bundschuh RA, Pabst KM, Kurtinecz M, Schmall A, Verholen F, Sartor O. Rahbar K, et al. Among authors: essler m. J Nucl Med. 2023 Dec 1;64(12):1925-1931. doi: 10.2967/jnumed.123.266125. J Nucl Med. 2023. PMID: 37827838 Free PMC article.

4

Key learnings from concordant systematic biopsies in prostate-specific membrane antigen positron emission tomography/computed tomography-guided prostate biopsies: Enhancing targeting accuracy.

Büttner T, Gärtner F, Essler M, Weiten R, Kristiansen G, Ellinger J, Ritter M, Krausewitz P. Büttner T, et al. Among authors: essler m. Prostate. 2024 Jun;84(8):772-779. doi: 10.1002/pros.24694. Epub 2024 Mar 20. Prostate. 2024. PMID: 38504659

5

Expression of the microtubule-associated protein 2 (MAP2) as a potential independent prognostic marker in prostate cancer.

Stein J, Krappe E, Kremer A, Cronauer MV, Essler M, Cox A, Klümper N, Krausewitz P, Ellinger J, Ritter M, Kristiansen G, Majores M. Stein J, et al. Among authors: essler m. J Cancer Res Clin Oncol. 2024 Feb 4;150(2):76. doi: 10.1007/s00432-023-05579-0. J Cancer Res Clin Oncol. 2024. PMID: 38310601 Free PMC article.

6

Deep learning enables automated MRI-based estimation of uterine volume also in patients with uterine fibroids undergoing high-intensity focused ultrasound therapy.

Theis M, Tonguc T, Savchenko O, Nowak S, Block W, Recker F, Essler M, Mustea A, Attenberger U, Marinova M, Sprinkart AM. Theis M, et al. Among authors: essler m. Insights Imaging. 2023 Jan 5;14(1):1. doi: 10.1186/s13244-022-01342-0. Insights Imaging. 2023. PMID: 36600120 Free PMC article.

7

US-guided high-intensity focused ultrasound in pancreatic cancer treatment: a consensus initiative between Chinese and European HIFU centers.

Zhou K, Strunk H, Dimitrov D, Vidal-Jove J, Gonzalez-Carmona MA, Essler M, Jin C, Mei Z, Zhu H, Marinova M. Zhou K, et al. Among authors: essler m. Int J Hyperthermia. 2024;41(1):2295812. doi: 10.1080/02656736.2023.2295812. Epub 2023 Dec 30. Int J Hyperthermia. 2024. PMID: 38159562 Free article.

8

The diagnostic value of ictal SPECT-A retrospective, semiquantitative monocenter study.

Schulte F, Bitzer F, Gärtner FC, Bauer T, von Wrede R, Baumgartner T, Rácz A, Borger V, von Oertzen T, Vatter H, Essler M, Surges R, Rüber T. Schulte F, et al. Among authors: essler m. Epilepsia Open. 2023 Mar;8(1):183-192. doi: 10.1002/epi4.12694. Epub 2023 Jan 30. Epilepsia Open. 2023. PMID: 36658093 Free PMC article.

9

Computational analysis of heat shock proteins and ferroptosis-associated lncRNAs to predict prognosis in acute myeloid leukemia patients.

Ge F, Wang Y, Sharma A, Jaehde U, Essler M, Schmid M, Schmidt-Wolf IGH. Ge F, et al. Among authors: essler m. Front Genet. 2023 Aug 1;14:1218276. doi: 10.3389/fgene.2023.1218276. eCollection 2023. Front Genet. 2023. PMID: 37600655 Free PMC article.

10

Cytokine-Induced Killer Cells in Combination with Heat Shock Protein 90 Inhibitors Functioning via the Fas/FasL Axis Provides Rationale for a Potential Clinical Benefit in Burkitt's lymphoma.

Ge F, Wang Y, Sharma A, Yang Y, Liu H, Essler M, Jaehde U, Schmidt-Wolf IGH. Ge F, et al. Among authors: essler m. Int J Mol Sci. 2023 Aug 5;24(15):12476. doi: 10.3390/ijms241512476. Int J Mol Sci. 2023. PMID: 37569852 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

214 results

Search Page